
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
A pocket guide to manage pediatric emergencies, an app to help diagnose a variety of eye conditions, and 3 other must-have emergency medicine apps for primary care physicians.






